Inventor · disambiguated record
John R. Cashman
Also filed as: CASHMAN JOHN · CASHMAN JOHN R
18 granted patents·7 pending applications·42 citations·filing 1998–2020
90Inventor score
Files withCASHMAN JOHN R10CASHMAN JOHN5HUMAN BIOMOLECULAR RES INSTITUTE3MERCOLA MARK3BURNHAM INST MEDICAL RESEARCH1
Top patents by PatentIndex Score
25 records- 0183US8778958B2Synthesis of metabolically stable agents for alcohol and drug abuseCASHMAN JOHN R·Filed 2009·Granted Jul 15, 2014·8 cites·11 claims
- 0275US9549991B2Chemical and biochemical adducts as biomarkers for organophosphate exposureCASHMAN JOHN R·Filed 2009·Granted Jan 24, 2017·2 cites·1 claims
- 0374US10874766B2Compounds and matrices for use in bone growth and repairHUMAN BIOMOLECULAR RES INSTITUTE·Filed 2014·Granted Dec 29, 2020·2 cites·10 claims
- 0473US8609708B2Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancerCASHMAN JOHN R·Filed 2010·Granted Dec 17, 2013·2 cites·3 claims
- 0573US8481501B2Synthesis of metabolically stable analgesics, pain medications and other agentsCASHMAN JOHN R·Filed 2005·Granted Jul 9, 2013·4 cites·15 claims
- 0672US6762052B1DNA sequence encoding flavin-containing monooxygenaseCASHMAN JOHN R·Filed 2000·Granted Jul 13, 2004·11 cites·4 claims
- 0765US9012217B2Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cellsMERCOLA MARK·Filed 2009·Granted Apr 21, 2015·1 cites·11 claims
- 0857US11596716B2Compounds and matrices for use in bone growth and repairHUMAN BIOMOLECULAR RES INSTITUTE·Filed 2020·Granted Mar 7, 2023·0 cites·10 claims
- 0954US2007286846A1Novel methods for ester detoxicationCASHMAN JOHN·Filed 2007·Application pending·0 cites
- 1052US10570088B2Blood brain barrier-penetrating oximes for cholinesterase reactivationHUMAN BIOMOLECULAR RES FOUNDATION·Filed 2017·Granted Feb 25, 2020·0 cites·14 claims
- 1152US2008188527A1Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung CancerCASHMAN JOHN R·Filed 2004·Application pending·0 cites
- 1251US10711037B2Chemical and biochemical adducts as biomarkers for organophosphate exposureHUMAN BIOMOLUCULAR RES INSTITUTE·Filed 2016·Granted Jul 14, 2020·0 cites·9 claims
- 1350US8168635B2Modulators of central nervous system neurotransmittersCASHMAN JOHN·Filed 2005·Granted May 1, 2012·0 cites·13 claims
- 1450US2009263492A1Diagnostic Methods and Genetic Markers for Alzheimer DiseaseCASHMAN JOHN R·Filed 2009·Application pending·0 cites
- 1549US2013123253A1Modulators of central nervous system neurotransmittersCASHMAN JOHN·Filed 2012·Application pending·0 cites
- 1649US2009247520A1INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-kappa B ACTIVATIONBURNHAM INST MEDICAL RESEARCH·Filed 2009·Application pending·0 cites
- 1748US9751831B2Blood brain barrier-penetrating oximes for cholistenerases reactivationCASHMAN JOHN R·Filed 2011·Granted Sep 5, 2017·0 cites·6 claims
- 1847US2012040976A1Small molecule immunomodulators for alzheimer's diseaseCASHMAN JOHN R·Filed 2009·Application pending·0 cites
- 1945US8906943B2Synthetic compounds and methods to decrease nicotine self-administrationCASHMAN JOHN R·Filed 2011·Granted Dec 9, 2014·0 cites·5 claims
- 2042US6365634B1Naturally occurring compounds and their derivatives as cyclooxygenase 2 and/or 5-lipoxygenase inhibitorsC P TECHNOLOGY LTD PARTNERSHIP·Filed 1998·Granted Apr 2, 2002·12 cites·19 claims
- 2139US11492325B2Compounds as inhibitors of sodium channelsHUMAN BIOMOLECULAR RES INSTITUTE·Filed 2017·Granted Nov 8, 2022·0 cites·21 claims
- 2239US9403800B2Compounds for inhibition of cancer cell proliferationCASHMAN JOHN·Filed 2013·Granted Aug 2, 2016·0 cites·6 claims
- 2337US9233926B2Compounds for stem cell differentiationMERCOLA MARK·Filed 2012·Granted Jan 12, 2016·0 cites·12 claims
- 2436US9023340B2Wnt inhibitors for human stem cell differentiationCASHMAN JOHN·Filed 2012·Granted May 5, 2015·0 cites·5 claims
- 2532US2011281356A1Compounds for stem cell differentiationMERCOLA MARK·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John R. Cashman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →